Tumor microenvironment complexity and therapeutic implications at a glance

R Baghban, L Roshangar… - Cell Communication and …, 2020 - Springer
The dynamic interactions of cancer cells with their microenvironment consisting of stromal
cells (cellular part) and extracellular matrix (ECM) components (non-cellular) is essential to …

Preclinical and clinical development of siRNA-based therapeutics

G Ozcan, B Ozpolat, RL Coleman, AK Sood… - Advanced drug delivery …, 2015 - Elsevier
The discovery of RNA interference, first in plants and Caenorhabditis elegans and later in
mammalian cells, led to the emergence of a transformative view in biomedical research …

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

CN Landen Jr, A Chavez-Reyes, C Bucana… - Cancer research, 2005 - AACR
Inducing destruction of specific mRNA using small interfering RNA (siRNA) is a powerful tool
in analysis of protein function, but its use as a therapeutic modality has been limited by …

[HTML][HTML] High-grade prostatic intraepithelial neoplasia

DG Bostwick, J Qian - Modern pathology, 2004 - Elsevier
High-grade prostatic intraepithelial neoplasia (PIN) is now accepted as the most likely
preinvasive stage of adenocarcinoma, almost two decades after its first formal description …

EphA2 overexpression causes tumorigenesis of mammary epithelial cells

DP Zelinski, ND Zantek, JC Stewart, AR Irizarry… - Cancer research, 2001 - AACR
Elevated levels of protein tyrosine phosphorylation contribute to a malignant phenotype,
although the tyrosine kinases that are responsible for this signaling remain largely unknown …

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

M Tandon, SV Vemula, SK Mittal - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Importance of the field: High mortality rates with cancers warrant further development of
earlier diagnostics and better treatment strategies. Membrane-bound erythropoietin …

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

C Hafner, G Schmitz, S Meyer, F Bataille… - Clinical …, 2004 - academic.oup.com
Background: Eph receptors and their ligands, the ephrins, represent a large class of cell–cell
communication molecules with well-defined developmental functions. Their role in healthy …

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

J Wykosky, W Debinski - Molecular Cancer Research, 2008 - AACR
The Eph receptor tyrosine kinases and ephrin ligands have been studied extensively for
their roles in developmental processes. In recent years, Eph receptors and ephrins have …

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

K Ogawa, R Pasqualini, RA Lindberg, R Kain… - Oncogene, 2000 - nature.com
Eph receptor tyrosine kinases and their ephrin ligands have been implicated in embryonic
vascular development and in in vivo models of angiogenesis. Eph proteins may also …

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

H Miao, BR Wei, DM Peehl, Q Li, T Alexandrou… - Nature cell …, 2001 - nature.com
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin
ligands critically regulate axon pathfinding and development of the cardiovascular system …